NEJM Journal Watch - In high-risk COVID-19 patients, the oral combination of nirmatrelvir plus ritonavir reduced hospitalization or death by almost 90%. https://jwat.ch/3IgojCU | Facebook
![NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals](https://www.jwatch.org/assets/images/jw_createAcctFlyout--mobile.png)
NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals
Do any patient subgroups benefit from... - NEJM Journal Watch | NEJM Journal Watch,temperature,Health & Medical,Science & Tech,cardiac,studies,subgroups,benefit,hypothermic | Facebook
NEW ENGLAND JOURNAL OF MEDICINE, NEJM JOURNAL WATCH, NEJM CATALYST INNOVATIONS IN CARE DELIVERY, and NEJM EVIDENCE INDIVIDUAL SU
![Editor-in-Chief of NEJM Journal Watch Reviewed Our Postdoctoral Fellow's Original Work published in JAMA Internal Medicine -川大护理学院英文站 Editor-in-Chief of NEJM Journal Watch Reviewed Our Postdoctoral Fellow's Original Work published in JAMA Internal Medicine -川大护理学院英文站](https://wcsn.scu.edu.cn/__local/5/77/08/97246B757D09D6E2F847AEF9C48_AC57852F_1B0C1.jpg)